Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.
from NDTV News - Latest https://ift.tt/3nX8fwP
Subscribe to:
Post Comments (Atom)
Women Gig Workers Lead Nationwide Protest, Demand Fair Wages, Social Security
Thousands of gig and platform service workers, led largely by women, staged a nationwide protest on Tuesday against what they described as w...
-
Using a spin on Prime Minister Narendra Modi's monthly address to the nation, Congress leaders Rahul Gandhi today urged the Central gove...
-
Thousands of user accounts for online government services in Canada were recently hacked during cyber attacks, authorities said Saturday. ...
-
Over 15,000 Indians live in the West African country, with some being in Ghana for over 70 years. Some families are now the fourth generatio...
No comments:
Post a Comment